Feud Prevents NIH, HHS From Teaming Up Against Science Fraud

The feud can be traced to a four-year investigation by the inspector general's office into procurement practices at NIH that led to the forced removal last spring of sciencetist Edwin Becker--(see The Scientist May 10, page 20). the HHS report accused NIH of wasting millions of dollars. Wyngaarden and the NIH community believe that the report exaggerated the extent of procurement problems at NIH and that Kusserwo simply does not understand the importance of providing scientists with easy and q

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The feud can be traced to a four-year investigation by the inspector general's office into procurement practices at NIH that led to the forced removal last spring of sciencetist Edwin Becker--(see The Scientist May 10, page 20). the HHS report accused NIH of wasting millions of dollars. Wyngaarden and the NIH community believe that the report exaggerated the extent of procurement problems at NIH and that Kusserwo simply does not understand the importance of providing scientists with easy and quick access to needed equipment—their reason for circumventing normal procedures.

Now Wyngaarden and his colleagues at NIH have another major bone to pick with HHS. Last month, Kusserow’s office issued a report (see story on page 1) that criticized NIH's handling of alleged misconduct cases. Wyn-gaarden views this as another unwarranted and uninformed swipe at the institutes’ practices.

"I’m getting a little tired of his attacks on the NIH," snapped Wyngaarden ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies